Literature DB >> 28530253

Sensitivity and specificity of vestibular bed-side examination in detecting VIII cranial nerve schwannoma with sensorineural sudden unilateral hearing loss as presenting symptom.

L Califano1, F Salafia1, M G Melillo1, S Mazzone1.   

Abstract

The objectives of this study were to identify signs of vestibular nerve suffering through a bedside vestibular examination protocol in case of sudden sensorineural unilateral hearing loss without spontaneous signs of vestibular impairment and to propose a bed-side vestibular examination based protocol for the focused execution of gadolinium-enhanced magnetic resonance imaging (MRI) only if a vestibular schwannoma is suspected. 96 patients, 52 men, 44 women, mean age 57.73 +/- 12.85 years, suffering from sudden sensorineural unilateral hearing loss, which presented neither vertigo nor spontaneous nystagmus, were enrolled. Pure tone audiometry, tympanometry, measurement of acoustic reflexes and Anderson test to detect adaptation, bedside vestibular examination through head shaking test, vibration test, head impulse test, hyperventilation test and detection of nystagmus in supine and lateral decubitus to search for signs of vestibular impairment were performed. Patients with signs of vestibular impairment and pure tone audiometry threshold at high frequencies better than 70 dB nHL were subjected to auditory brainstem responses. Gadolinium enhanced MRI centred on internal acoustic canals was carried out in all patients with sudden sensorineural unilateral hearing loss. Main outcome measures were signs of vestibular impairment at vestibular bedside examination and presence of vestibular schwannoma on MRI. Signs of vestibular impairment were detected in 22/96 cases (22.9%); a vestibular schwannoma was detected by MRI in 5/96 cases (5.2%), always when vestibular impairment was present. In case of sudden sensorineural unilateral hearing loss, vestibular bedside examination seems to be useful to restrict the suspicion of a vestibular schwannoma to cases with signs of vestibular impairment, reducing the number of MRI exams, with considerable economic savings. © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.

Entities:  

Keywords:  Sudden Sensorineural Hearing Loss; Vestibular Schwannoma; Vestibular bed-side examination

Mesh:

Year:  2017        PMID: 28530253      PMCID: PMC5584107          DOI: 10.14639/0392-100X-1284

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


Introduction

Vestibular schwannoma (VS) represents about 80% of cerebellopontine angle tumours, 90% of intra-cranial schwannomas and 5-10% of all intra-cranial tumours. Its most common origin is from the superior branch of the vestibular nerve, but some studies on the temporal bone have identified its origin from the cochlear branch of the 8th cranial nerve in 24% of the cases . The incidence of VS seems to be increasing, both because of improvements in diagnostic techniques and the presence of supposed favouring factors, such as electromagnetic pollution ; there is no sex predilection and the peak of incidence is between 50 and 60 years old; it usually occurs in isolated forms, as opposed to the multiple lesions often observed in neurofibromatosis type 2, which is caused by mutations in the NF2 tumour suppressor gene on chromosome 22. The most common symptoms of VS are progressive unilateral sensorineural hearing loss, tinnitus and postural instability. Sudden sensorineural unilateral hearing loss (SSUHL) can be the presenting symptom in 2%-10% of the cases, whereas it occurs in 20-25% of cases during the natural history of the tumour -. Sudden hearing loss is defined as "a rapid onset, occurring over a 72-hour period, of a subjective sensation of hearing impairment in one or both ears. The most frequent used audiometric criterion is a decrease in hearing of ≥ 30 decibels (dB) affecting at least 3 consecutive frequencies" . SSUHL seems to be more common in intracanalicular tumours and in young patients ; its complete resolution is possible so that even in the case of a recovered SSUHL, magnetic resonance imaging (MRI), which is the diagnostic gold standard for VS, is recommended. It is reasonable to think that suffering of the superior vestibular nerve could cause clinical signs of vestibular impairment, recognisable through a vestibular bedside examination protocol. The objectives were: to identify signs of vestibular nerve suffering through a bedside vestibular examination protocol-head shaking test (HST), vibration test (VT), head impulse test (HIT), hyperventilation test (HVT) and detection of nystagmus in supine and lateral decubitus; to propose a clinical protocol for the focused execution of gadolinium-enhanced MRI only if a VS is clinically suspected.

Materials and methods

From January 2013 to December 2015 we observed 96 cases (52 men, 44 women, mean age 57.73 ± 12.85 years) of apparently idiopathic SSUHL, that presented neither vertigo nor spontaneous nystagmus in the sitting position. In particular, we investigated in the absence of barotrauma, acute acoustic trauma or other trauma as causes of SSUHL. Seven individuals referred a previous diagnosis of benign paroxysmal positional vertigo. Pure tone audiometry, tympanometry, measurement of acoustic reflexes and Anderson test were performed in all patients. Diagnosis of SSUHL was based on the criterion exposed in the previously reported guidelines . In SSHUL patients and in a homogeneous control group of 20 individuals (11 men, 9 women, mean age 56.75±14.53 years (p = 0.76)) with no medical history of audiological, vestibular or neurological diseases, we searched for signs of vestibular impairment under infra-red binocular videonystagmoscopy: head shaking induced nystagmus (HSIN), vibration induced nystagmus (VIN), hyperventilation induced nystagmus (HVIN), and positional nystagmus in both the supine position and lateral decubitus, and compensatory saccades evoked through HIT. Patients with one or more signs of vestibular impairment performed ABR, if the tonal threshold in the range 2000- 4000 Hz was better than 70 dB nHL. Criteria of suspect for VS were considered: absence of waves in relation to the pure tone audiometry data; lengthening of I-III and I-V interpeaks and lengthening of wave V absolute latency. All patients affected by SSUHL underwent gadolinium- enhanced MRI centred on internal auditory canals.

Main outcome measures

We considered: the presence of signs of vestibular impairment and the presence of VS on MRI.

Statistical analysis

Fisher's exact test was performed to compare: a) diagnosis of VS by MRI with vestibular bedside examination results; b) data on vestibular impairment in the VS group: one sign vs. at least two signs of vestibular suffering and both groups with vestibular impairment vs. the group without vestibular impairment; c) vestibular bedside examination results of the SSUHL group vs. the control group. An unpaired t test was used to compare the mean age of the SSUHL group with the control group. In both tests, a P value < 0.05 was considered significant.

Results

Audiometric tests. A flat configuration hearing loss was observed in 50/96 patients (pure tone average from 250 to 8000 Hz: 54.3 ± 10.24 dB; range: 45-94.5 dB); a sloping configuration in 28/96 patients (pure tone average from 250 to 8000 Hz: 38.5 ± 15.64 dB; range: 28.5-56.3 dB); a rising configuration in 10/96 patients (pure tone average from 250 to 8000 Hz: 33.5 ± 9.40 dB; range: 25.5-50.3 dB); a "U" shaped configuration- greatest hearing loss in the mid-frequency range- in 8/96 patients (pure tone average from 250 to 8000 Hz: 36.5 ± 12.65 dB; range: 30.5-55.3 dB). In all cases, the criterion for a decrease in hearing of ≥ 30 decibels (dB) affecting at least 3 consecutive frequencies was respected . At least two signs of vestibular impairment were found in 4/96 patients (4.2%) (Table I). Only one sign of vestibular impairment was found in 18/96 patients (18.8%) (Table II). On the whole, vestibular impairment was observed in 22/96 patients (22.9%). In the control group, no signs of vestibular impairment were observed, with a significant difference vs. the SSUHL group (p = 0.02).
Table I.

Results of vestibular bed-side examination in cases with at least two positive tests.

HSINVINHVINHITSupine position nystagmusSchwannoma (MRI)
Case 1PareticPareticAbsentNo saccadesAbsentNo
Case 2PareticPareticPareticNo saccadesParetic12 mm
Case 3PareticExcitatoryPareticNo saccadesAbsent13 mm
Case 4AbsentPareticExcitatoryNo saccadesAbsent8 mm

HSIN: Head Shaking Induced Nystagmus; VIN: Vibration Induced Nystagmus; HVIN: Hyperventilation Induced Nystagmus; HIT: Head Impulse Test; paretic: nystagmus with fast phases directed toward the healthy side; excitatory: nystagmus with fast phases directed toward the affected side (hearing loss); MRI: Magnetic Nuclear Imaging

Table II.

Results of vestibular bed-side examination in cases with one positive test.

HSINVINHVINHTTSupine position nystagmusSchwannoma (MRI)
Case 1AbsentAbsentExcitatoryNo saccadesAbsent6 mm
Case 2PareticAbsentAbsentNo saccadesAbsentNo
Case 3AbsentPareticAbsentNo saccadesAbsent12 mm
Case 4AbsentPareticAbsentNo saccadesAbsentNo
Case 5PareticAbsentAbsentNo saccadesAbsentNo
Case 6AbsentPareticAbsentNo saccadesAbsentNo
Case 7AbsentPareticAbsentNo saccadesAbsentNo
Case 8AbsentAbsentAbsentNo saccadesPareticNo
Case 9PareticAbsentAbsentNo saccadesAbsentNo
Case 10PareticAbsentAbsentNo saccadesAbsentNo
Case 11AbsentAbsentAbsentNo saccadesPareticNo
Case 12AbsentPareticAbsentNo saccadesAbsentNo
Case 13PareticAbsentAbsentNo saccadesAbsentNo
Case 14AbsentPareticAbsentNo saccadesAbsentNo
Case 15AbsentPareticAbsentNo saccadesAbsentNo
Case 16AbsentPareticAbsentNo saccadesAbsentNo
Case 17AbsentPareticAbsentNo saccadesAbsentNo
Case 18PareticAbsentAbsentNo saccadesAbsentNo

HSIN: Head Shaking Induced Nystagmus; VIN: Vibration Induced Nystagmus; HVIN: Hyperventilation Induced Nystagmus; HIT: Head Thrust Test; paretic: nystagmus with fast phases directed toward the healthy side; excitatory: nystagmus with fast phases directed toward the affected side (hearing loss); MRI: Magnetic Resonance Imaging

Results of vestibular bed-side examination in cases with at least two positive tests. HSIN: Head Shaking Induced Nystagmus; VIN: Vibration Induced Nystagmus; HVIN: Hyperventilation Induced Nystagmus; HIT: Head Impulse Test; paretic: nystagmus with fast phases directed toward the healthy side; excitatory: nystagmus with fast phases directed toward the affected side (hearing loss); MRI: Magnetic Nuclear Imaging Results of vestibular bed-side examination in cases with one positive test. HSIN: Head Shaking Induced Nystagmus; VIN: Vibration Induced Nystagmus; HVIN: Hyperventilation Induced Nystagmus; HIT: Head Thrust Test; paretic: nystagmus with fast phases directed toward the healthy side; excitatory: nystagmus with fast phases directed toward the affected side (hearing loss); MRI: Magnetic Resonance Imaging ABR was performed on 16/22 patients with vestibular impairment. In 2/5 of the cases in which MRI demonstrated a VS, we observed the lengthening of I-III and I-V interpeak latencies, which are the most specific signs of suspicion for VS; in three cases we observed the lengthening of Wave V absolute latency, which is a less specific sign of neural suffering ; in fact, it was the most frequent finding in the 11 cases that were MRI-negative for VS. In these cases, when evaluable, I-III and I-V inter-latencies were normal. MRI revealed the presence of VS in 3/4 cases in the group with at least two signs of vestibular impairment (Table I) and in 2/18 cases in the group with only one sign of vestibular impairment. VS was never found in the 74 cases without signs of vestibular impairment. Incidence of VS in the population affected by SSUHL was 5.2% (5/96 patients). The differences were statistically significant: p < 0.001 for the group with at least two signs of vestibular impairment vs. the group without vestibular impairment; p = 0.03 for the group with one sign of vestibular impairment vs. the group with no sign of vestibular impairment; p = 0.02 for the group with at least two signs vs. the group with one sign of vestibular impairment. A flat configuration hearing loss (pure tone average 250-8000 Hz: 54 dB and 50 dB) was observed in two cases MRI positive for VS, in three cases a sloping configuration (pure tone average: 35.5 dB, 37.5 dB, 40.5 dB). No significant difference was noted for the pure tone average vs. the cases MRI negative for VS. The Anderson test was positive in 4/5 cases MRI positive for VS, but it was also positive in six cases that were MRI negative for VS (sensitivity = 80%; specificity = 64.7%). In relation to the detection of VS, vestibular bedside examination presented a sensitivity of 60%, a specificity of 98.8% and a positive predictive value of 75% in the group with at least 2 signs of vestibular impairment (4/96 cases); a sensitivity of 100%, a specificity of 81.3% and a positive predictive value of 22.7% % in the group with at least one sign of vestibular impairment (22/96 cases).

Discussion

Diagnosis of VS is sometimes "elusive" because its symptoms can be slowly progressive, especially unilateral hearing loss and postural instability. VS can be suspected through standard audiological and vestibular functionality examinations, but the diagnostic gold standard is gadolinium- enhanced MRI which must be performed in all cases with both clinical and functional suspicion. In a low percentage of cases, SSUHL was identified as a possible presenting symptom of a VS ; however, since SSUHL can occur in a higher percentage of VS cases-up to 20% during the natural history of the tumour, an MRI of the internal auditory canals is recommended in cases of apparently idiopathic SSUHL . Notwithstanding, since SSUHL is a revealing symptom of VS in only a few cases, most MRIs do not reveal the suspected disease, with an obvious waste of economic resources. For this reason, it would be useful to develop a diagnostic protocol able to identify a suspect VS, with high sensitivity and specificity, especially when SSUHL is the presenting symptom. Since the preferential origin of the VS is from the superior branch of the vestibular nerve, it makes sense to seek dynamic, static and metabolic signs of vestibular imbalance through a vestibular bedside examination that can be performed in less than 10 minutes. Teggi et al. showed that intracanalicular length and intracanalicular diameter seem to be the main parameters that correlate with vestibular function and that also in case of small intracanalar VS a vestibular impairment is possible; Niu observed caloric hyporeflexia in 50% patients with SSUHL without vertigo. Our data suggested vestibular impairment in 22/96 patients (22.9%). The vestibular bedside examination tests showed results in line with our previous studies ; VT presented the most frequent number of positive cases associated with VS (4/5 cases), even if the significance of the data is limited by the small number of VS cases it was related to. HIT did not show any positivity. This is not unexpected, because the occurrence of compensatory saccades to HIT is related to the presence of a serious vestibular hyporeflexia , which is not necessarily present in the small tumours that are the object of the present study (6-13 mm), as highlighted by MRI. Furthermore, HIT was performed in its clinical form; video-HIT could possibly improve its diagnostic sensitivity. A possible bias is that the positivity of vestibular tests could be related to a previous suffering of the system. The bias can be minimised by careful medical history. However, such a situation would lower the specificity and not the sensitivity of the vestibular bedside examination. In other words, we would have detected all the VS, carrying out most MRI. VS, identified through gadolinium-based MRI of internal auditory canals, presented an incidence of 5.2%-5/96 cases, all in the group of 22 patients with one or more signs of vestibular impairment, whereas VS was not found in patients with no sign of vestibular impairment (p < 0.0001). The above percentage is in agreement with previous studies that identified SSUHL as a rare VS revealing symptom . Nevertheless, we must again consider that our results are limited by the low number of VS identified, even if their number is consistent with the predictable one.

Conclusions

In case of unilateral sensorineural hearing loss it is mandatory to exclude VS as its cause. SSUHL is reported as the presenting symptom of VS in > 10% of the cases, but MRI is considered to be the gold standard test to exclude VS in case of SSUHL, too. We propose to immediately perform MRI to detect a possible VS in case of SSUHL as presenting symptom only when a vestibular impairment is present; a cut-off value at two signs makes the protocol very specific (98.8%), but less sensitive (60%); nevertheless, a cut-off value at one sign decreases its specificity to 81.3%, whereas its sensitivity is increased to 100%. If a cut-off value at two signs is chosen, in cases with only one sign of vestibular impairment, to increase the sensitivity of our analysis, we recommend performing ABR before an MRI is carried out. In any case, even the decision to carry out MRI on all patients with at least one sign of vestibular asymmetry, would decrease significantly its number: according to our results, MRI would have been carried out only in 22/96 cases, with considerable economic savings. Audiometric and clinical follow-up will suggest MRI if new data eventually augment the suspect of the presence of VS. In our opinion, for its simplicity of execution, sensitivity and specificity, vestibular bedside examination is indicated in all cases of apparently idiopathic SSUHL. A possible decisional flow-chart is represented in Figure 1.
Fig. 1

Decision making flow-chart for sensorineural unilateral sudden hearing loss.

Decision making flow-chart for sensorineural unilateral sudden hearing loss.
  17 in total

1.  Vestibular schwannoma presenting as sudden deafness.

Authors:  Y Inoue; J Kanzaki; K Ogawa
Journal:  J Laryngol Otol       Date:  2000-08       Impact factor: 1.469

2.  Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma.

Authors:  Elisabeth Sauvaget; Sammy Kici; Romain Kania; Philippe Herman; Patrice Tran Ba Huy
Journal:  Acta Otolaryngol       Date:  2005-06       Impact factor: 1.494

3.  The clinical characteristics and treatment for sudden sensorineural hearing loss with vestibular schwannoma.

Authors:  Chang Lin; Qilin Gong; Wenjing Zuo; Rong Zhang; Aidong Zhou
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-23       Impact factor: 2.503

4.  Clinical practice guideline: sudden hearing loss.

Authors:  Robert J Stachler; Sujana S Chandrasekhar; Sanford M Archer; Richard M Rosenfeld; Seth R Schwartz; David M Barrs; Steven R Brown; Terry D Fife; Peg Ford; Theodore G Ganiats; Deena B Hollingsworth; Christopher A Lewandowski; Joseph J Montano; James E Saunders; Debara L Tucci; Michael Valente; Barbara E Warren; Kathleen L Yaremchuk; Peter J Robertson
Journal:  Otolaryngol Head Neck Surg       Date:  2012-03       Impact factor: 3.497

5.  Vestibular assessment in patients with vestibular schwannomas: what really matters?

Authors:  R Teggi; A Franzin; G Spatola; N Boari; P Picozzi; M Bailo; L O Piccioni; F Gagliardi; P Mortini; M Bussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

6.  Sudden deafness as the presenting symptom of acoustic neurinoma.

Authors:  W A Higgs
Journal:  Arch Otolaryngol       Date:  1973-08

7.  What is the site of origin of cochleovestibular schwannomas?

Authors:  Christof Roosli; Fred H Linthicum; Sebahattin Cureoglu; Saumil N Merchant
Journal:  Audiol Neurootol       Date:  2011-09-29       Impact factor: 1.854

8.  Sudden hearing loss as a presenting symptom of acoustic neuroma.

Authors:  M Chaimoff; B I Nageris; J Sulkes; T Spitzer; M Kalmanowitz
Journal:  Am J Otolaryngol       Date:  1999 May-Jun       Impact factor: 1.808

9.  Sudden hearing loss induced by acoustic neuroma: significance of small tumors.

Authors:  N Yanagihara; M Asai
Journal:  Laryngoscope       Date:  1993-03       Impact factor: 3.325

10.  Recovery from repeated sudden hearing loss with corticosteroid use in the presence of an acoustic neuroma.

Authors:  L P Berenholz; C Eriksen; F A Hirsh
Journal:  Ann Otol Rhinol Laryngol       Date:  1992-10       Impact factor: 1.547

View more
  1 in total

1.  Sudden sensorineural hearing loss as the initial symptom in patients with acoustic neuroma.

Authors:  Mengtao Song; Dayong Wang; Jin Li; Guohui Chen; Xiaolong Zhang; Hongyang Wang; Qiuju Wang
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.